Results 51 to 60 of about 103,858 (377)

Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity [PDF]

open access: yes, 2018
Transfusion of red cell concentrates (RCCs) is associated with increased risk of adverse outcomes that may be affected by different blood manufacturing methods and the presence of extracellular vesicles (EVs).
Acker, Jason P.   +9 more
core   +3 more sources

Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study

open access: yesHematological Oncology, Volume 40, Issue 5, Page 1056-1066, December 2022., 2022
Abstract Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outcomes.
Tine Bichel Lauritsen   +4 more
wiley   +1 more source

Blood product transfusion in emergency department patients: A case-control study of practice patterns and impact on outcome [PDF]

open access: yes, 2017
Definitions of comorbid conditions.
Beyer, Alexander   +4 more
core   +3 more sources

Prophylactic platelet transfusions

open access: yesCurrent Opinion in Hematology, 2010
This review highlights the recent research on the use of prophylactic platelet transfusions, which is a topic that still provokes controversy. Over the last 12 months, there have been several studies with important new findings.Two randomized controlled trials compared different doses of prophylactic platelet transfusions in patients with ...
Estcourt, L, Stanworth, S, Murphy, M
openaire   +4 more sources

Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study

open access: yesBMC Gastroenterology, 2020
Background Chronic liver disease (CLD) is often complicated by severe thrombocytopenia (platelet count  50,000/µL at baseline: the proportions of patients who did not require platelet transfusion were 84–96%, which might be overestimated.
Hiroaki Nomoto   +11 more
doaj   +1 more source

Structure and thermodynamics of platelet dispersions [PDF]

open access: yesMolec. Phys. 106, 1975 (2008), 2008
Various properties of fluids consisting of platelike particles differ from the corresponding ones of fluids consisting of spherical particles because interactions between platelets depend on their mutual orientations. One of the main issues in this topic is to understand how structural properties of such fluids depend on factors such as the shape of ...
arxiv   +1 more source

Platelet transfusions in hematological disorders [PDF]

open access: yes, 2021
Platelets are important for clot formation and vascular integrity. Thrombocytopenic patients with hematological disorders are at risk of bleeding and platelet transfusions are important in supportive care and treatment of lite-threatening bleedings ...
Karlström, Cecilia
core   +1 more source

Coexisting Cardiac and Hematologic Disorders. [PDF]

open access: yes, 2016
Patients with concomitant cardiac and hematologic disorders presenting for noncardiac surgery are challenging. Anemic patients with cardiac disease should be approached in a methodical fashion.
Goldhammer, Jordan E., Kohl, Benjamin A.
core   +3 more sources

Comparison of three commercially available buffy coat pooling sets for the preparation of platelet concentrates [PDF]

open access: yes, 2018
Background: A disposable set for platelet concentrate (PC) preparation by the buffy coat method allows pooling of buffy coats, centrifugation and cell separation with in-line leucocyte filtration.
Aelst   +11 more
core   +2 more sources

Transfusion efficacy and influencing factors of patients transfused with different therapeutic doses of platelets: a comparative analysis

open access: yesZhongguo shuxue zazhi
[Objective] To compare and analyze the efficacy of platelet transfusion in patients with different doses, and to analyze the risk factors for platelet transfusion refractoriness.
ZHU Jianling   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy